Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla-C Dubinsky

Showing results (141-150 of 247) with videos related to

Pageof 25
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 13, 2023
Emergent Subtotal Colectomies Have Higher Leak Rates in Subsequent J-Pouch StagesMichael C Plietz, Marine Coste, Jeremy Miller, et al.
The American Journal of Gastroenterology|January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximabKonstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
Crohn'S & Colitis 360|February 13, 2023
Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's DiseaseCorey A Siegel, Lori S Siegel, Marla C Dubinsky, et al.
BMC Gastroenterology|February 20, 2022
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
Inflammatory Bowel Diseases|March 4, 2025
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical ProgramBruce E Sands, Marla C Dubinsky, Paulo G Kotze, et al.
Crohn'S & Colitis 360|February 13, 2023
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug MonitoringAmy Hemperly, Marla C Dubinsky, Andres Yarur, et al.
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
Inflammatory Bowel Diseases|June 10, 2023
Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient SurveyFlorence-Damilola Odufalu, Marla C Dubinsky, Laurent Peyrin-Biroulet, et al.
BMJ Open Gastroenterology|September 1, 2025
Etrasimod for the symptomatic relief of ulcerative colitis: a post-hoc analysis from the ELEVATE UC clinical programmeMaría Chaparro, Remo Panaccione, Bruce E Sands, et al.
Journal of Pharmacy Practice|April 8, 2021
Improved Smoking Cessation Rates in a Pharmacist-Led Program Embedded in an Inflammatory Bowel Disease Specialty Medical HomeStacy Saithy Tse, Bruce E Sands, Laurie Keefer, et al.
Pageof 25

Showing results (141-150 of 247) with videos related to

Sort By:
Pageof 25
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 13, 2023
Emergent Subtotal Colectomies Have Higher Leak Rates in Subsequent J-Pouch StagesMichael C Plietz, Marine Coste, Jeremy Miller, et al.
The American Journal of Gastroenterology|January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximabKonstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
Crohn'S & Colitis 360|February 13, 2023
Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's DiseaseCorey A Siegel, Lori S Siegel, Marla C Dubinsky, et al.
BMC Gastroenterology|February 20, 2022
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
Inflammatory Bowel Diseases|March 4, 2025
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical ProgramBruce E Sands, Marla C Dubinsky, Paulo G Kotze, et al.
Crohn'S & Colitis 360|February 13, 2023
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug MonitoringAmy Hemperly, Marla C Dubinsky, Andres Yarur, et al.
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
Inflammatory Bowel Diseases|June 10, 2023
Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient SurveyFlorence-Damilola Odufalu, Marla C Dubinsky, Laurent Peyrin-Biroulet, et al.
BMJ Open Gastroenterology|September 1, 2025
Etrasimod for the symptomatic relief of ulcerative colitis: a post-hoc analysis from the ELEVATE UC clinical programmeMaría Chaparro, Remo Panaccione, Bruce E Sands, et al.
Journal of Pharmacy Practice|April 8, 2021
Improved Smoking Cessation Rates in a Pharmacist-Led Program Embedded in an Inflammatory Bowel Disease Specialty Medical HomeStacy Saithy Tse, Bruce E Sands, Laurie Keefer, et al.
Pageof 25